Biohacking Autism published an episode featuring co-author John Slattery of the 2018 randomized, double-blind, placebo-controlled trial of folinic acid in children with autism and language impairment.
Published
Signal category
Research & Knowledge
Quote
“Today's episode does that, with John Slattery, co-author of the 2018 randomized, double-blind, placebo-controlled trial of folinic acid in children with autism and language impairment.”
— Nadia Elkhatib|Biohacking Autism team
Company
Biohacking Autism
Biohacking, functional medicine, and longevity science for autism families. Real solutions, parent to parent.
- Industry
- Wellness and Fitness Services
- Company size
- 1 employees
Biohacking Autism is a weekly podcast hosted by Nadia Elkhatib, bringing biohacking, functional medicine, peptides, and longevity science directly to autism families. We interview researchers, clinicians, and innovators working at the intersection of neuroscience, environmental health, and neurodevelopment. Our guests include published researchers from institutions like Harvard, Stanford, Hebrew University, and UC Davis, along with clinicians pioneering integrative approaches to autism. Our focus areas include neuroinflammation, gut health, mitochondrial function, hormone optimization, environmental toxins, sleep science, and emerging therapeutics. The podcast launched in March 2026 and has reached listeners in 20+ countries. Available on Apple Podcasts, Spotify, and YouTube. biohackautism.com